PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus
Yin Tong(Zhejiang University), Wenbin Qian(Ministry of Education of the People's Republic of China)
Cited by 40
Related Papers
Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo
|Journal of Experimental & Clinical Cancer Research|2018|86
Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells
|International Journal of Oncology|2016|42
CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy
|Blood Advances|2024|40
MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells
|Acta Pharmacologica Sinica|2018|25